Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts
- 1 October 1995
- Vol. 108 (4) , 424S-430S
- https://doi.org/10.1378/chest.108.4_supplement.424s
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts Following Percutaneous Transluminal Coronary AngioplastyChest, 1992
- Starting aspirin therapy after operation. Effects on early graft patency. Department of Veterans Affairs Cooperative Study Group.Circulation, 1991
- Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study.Circulation, 1991
- Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.Circulation, 1989
- Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study.Circulation, 1988
- Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass graftsThe Journal of Thoracic and Cardiovascular Surgery, 1985
- Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion.Heart, 1985
- IMPROVED AORTOCORONARY BYPASS PATENCY BY LOW-DOSE ASPIRIN (100 mg DAILY)The Lancet, 1984
- Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass OperationsNew England Journal of Medicine, 1984
- Influence of Aspirin and Dipyridamole on Patency of Coronary Artery Bypass GraftsThe Annals of Thoracic Surgery, 1981